32 Stocks Moving In Monday's Mid-Day Session

Gainers

• BioDelivery Sciences International, Inc. BDSI shares jumped 51.9% to $5.53. Collegium Pharmaceutical will acquire BioDelivery Sciences International at $5.60 per share in an all-cash transaction, corresponding to an equity value of approximately $604 million.
• Motus GI Holdings, Inc. MOTS jumped 28.8% to $0.5474 after declining 6% on Friday.
• Cornerstone Building Brands, Inc. CNR gained 24.3% to $22.86 as private equity firm CD&R offered to acquire all outstanding shares it does not already own of Cornerstone Building Brands for $24.65 per share in cash.
• Knightscope, Inc. KSCP surged 23.2% to $7.78 after the company announced a partnership with Allied Universal to provide autonomous security robots.
• TC Biopharm (Holdings) Plc TCBP shares gained 22.8% to $2.6050. The company’s shares dropped 50% on Friday after the company priced its IPO at $4.25 per ADS.
• Astrea Acquisition Corp. ASAX surged 16.4% to $9.74 after the company, HotelPlanner and Reservations.com mutually agreed to terminate their business combination agreement.
• Kelly Services, Inc. KELYA jumped 15.6% to $19.95 after the company reported Q4 earnings results.
• Collegium Pharmaceutical, Inc. COLL surged 14.3% to $20.10 after the company announced it will acquire BioDelivery Sciences.
• Reliance Global Group, Inc. RELI gained 12.8% to $6.60.
• Freshworks Inc. FRSH surged 10.4% to $20.32. Freshworks recently reported Q4 earnings results.
• BioVie Inc. BIVI surged 9.5% to $3.45.
• VTEX VTEX gained 9.2% to $8.27. Credit Suisse initiated coverage on Vtex with a Neutral rating and announced a price target of $10.
• UserTesting, Inc. USER jumped 8.3% to $9.32. UserTesting is expected to announce Q4 financial results on February 28, 2022.
• DiDi Global Inc. DIDI gained 7.3% to $4.28. Bernstein initiated coverage of DiDi Global with an Outperform rating and $6.20 price target, implying an upside of 55.4%.

Also check out this: Insiders Buying These 4 Penny Stocks

Losers

• Dave Inc. DAVE shares dipped 34% to $6.15. Dave recently appointed Michael Pope to Board of Directors.
• RumbleON, Inc. RMBL dropped 29.2% to $27.25 as the company disclosed senior management changes. The company’s President Peter Levy will succeed Mark Tkach as COO.
• Bright Health Group, Inc. BHG declined 23% to $2.94. Bright Health Group is expected to report Q4 financial results on Wednesday, March 2, 2022.
• Sea Limited SE dropped 17.6% to $130.40. JP Morgan maintained Sea with an Overweight and lowered the price target from $420 to $250.
• Gravity Co., Ltd. GRVY fell 16.2% to $51.78. Gravity reported prelim FY21 consolidated revenue of KRW414 billion.
• Weber Inc. WEBR fell 16.1% to $8.76 after the company reported worse-than-expected Q1 EPS and sales results.
• Modular Medical, Inc. MODD fell 15% to $3.62. Modular Medical shares jumped around 15% on Friday following its recent uplisting to the Nasdaq Capital Market on Thursday.
• InterCure Ltd. INCR shares fell 14.6% to $7.00 after jumping 22% on Friday. Intercure recently reported preliminary Q4 revenue.
• BRC Inc. BRCC dipped 13.6% to $14.06.
• Moderna, Inc. MRNA dropped 12.9% to $140.52. The European Medicines Agency's safety committee is reviewing reports of heavy menstrual bleeding and absence of menstruation after COVID-19 vaccines from Pfizer / BioNTech, and Moderna.
• Agrify Corporation AGFY fell 11.7% to $7.51.
• Leafly Holdings, Inc. LFLY dipped 10.5% to $6.36.
• Novavax, Inc. NVAX dropped 9.4% to $81.95. Novavax recently said that its two-dose COVID-19 vaccine was 80% overall effective against COVID-19 in a late-stage trial testing the shot in teens aged 12 to 17 years.
• IceCure Medical Ltd ICCM shares fell 8.5% to $2.66. IceCure Medical recently said it sees preliminary FY21 revenues of $4.1 million, up from $3.9 million year-over-year.
• CF Industries Holdings, Inc. CF dropped 8% to $70.38.
• Standard Lithium Ltd. SLI fell 8% to $5.92. Hindenburg Research recently issued a bearish report on Standard Lithium.
• Senseonics Holdings, Inc. SENS fell 6.8% to $2.2550. The FDA recently approved the company’s Eversense E3 Continuous Glucose Monitoring (CGM) System.
• Zosano Pharma Corporation ZSAN fell 6% to $0.2072. Zosano Pharma recently announced pricing of a $15.4 million public offering of common stock and warrants.

Also check out this: Discover Financial Services And 3 Other Stocks Sold By Insiders